Law360, New York ( April 4, 2011, 5:46 PM EDT) -- Cubist Pharmaceuticals Inc. struck a licensing deal with Teva Pharmaceutical Industries Ltd. on Monday to resolve patent infringement litigation over a proposed generic version of Cubist's IV antibiotic Cubicin, allowing Teva to roll out its generic by 2018....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.